SYBX News and Press, Synlogic Inc. From 12/27/23

2023-12-27 08:02:38 ET More on Synlogic Synlogic earns $2.5 million milestone payment from Roche collaboration Synlogic down 4%, priced $21M offering Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial infor...

CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, announced that it has entered into an approximately $1 million subc...

- Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation - CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, o...

NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 15-16, 2023. The presentation schedule is...

2023-11-09 07:52:09 ET More on Synlogic Synlogic earns $2.5 million milestone payment from Roche collaboration Synlogic down 4%, priced $21M offering Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial infor...

- Underwritten public offering of $21.0 million and earned $2.5 million milestone payment from Roche have extended cash runway into the first half of 2025 - - Progress of the Synpheny-3 pivotal trial in phenylketonuria (PKU) supports enrollment completion in 2024, with top-line ...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Synlogic Inc. (SYBX) is expected to report $-2.55 for Q3 2023

2023-11-07 07:33:30 ET More on Synlogic Synlogic down 4%, priced $21M offering Synlogic announces 1-for-15 reverse stock split Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial information for Synlogic ...

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, announced today that it has achieved its third pre-specified resear...